We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kings Arms Yard Vct Plc | LSE:KAY | London | Ordinary Share | GB0007174294 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.40 | 18.90 | 19.90 | 19.40 | 19.40 | 19.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 3.32M | 726k | 0.0014 | 138.57 | 100.91M |
TIDMKAY
DIRECTORATE CHANGE
KINGS ARMS YARD VCT PLC
LEI Code 213800DK8H27QY3J5R45
This announcement includes information required under Listing Rule 9.6.
As part of its succession planning, the Board of Kings Arms Yard VCT PLC ("the Company") is pleased to announce the appointment of Swarupa Pathakji and Dr John Chiplin as non-executive Directors of the Company with effect from 1 November 2021.
Swarupa has extensive experience across the financial sector, with an in-depth understanding of investment in growth companies, experience in exits and valuations. She qualified as a chartered accountant at Deloitte before spending time in mergers and acquisitions at Merrill Lynch. She moved to Duke Street, a mid-market Private Equity fund manager, in 2007 and has served as a non-executive Director on the Boards of a number of companies across multiple sectors. She is currently non-executive Director of OFS (DS) Holdings Ltd where she is chair of the Audit Committee.
Swarupa will succeed Thomas Chambers as Chair of the Audit Committee on his retirement from the role.
John has extensive experience and expertise in the life sciences and technology sectors from both an operational and investment perspective. He is Chairman of Scancell Holdings plc, N4 Pharma plc and Biotherapy Services Limited. He is also Managing Director of Newstar Ventures Ltd.
John was head of the ITI Life sciences investment fund in the UK and has managed the mergers, acquisitions and listing of a number of blue-chip companies. He also serves on the Boards of an Australian public company, Regeneus, and US private company Batu Biologics. He joins the Board at a time when increasing numbers of technology and healthcare investment opportunities are being considered and so his experience in these areas will be invaluable.
The Board welcomes Swarupa and John and looks forward to working with them both over the coming years.
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850
29 October 2021
(END) Dow Jones Newswires
October 29, 2021 07:00 ET (11:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Kings Arms Yard Vct Chart |
1 Month Kings Arms Yard Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions